Innovative peer and family support for preventing youth suicide in Nepal
Innovations for peer-delivered and family-engaged brief interventions for youth suicide in Nepal: A pilot hybrid type 2 implementation study
This study is working on new ways to help prevent suicide in young people aged 12-24 in Nepal by using friendly peer support and family involvement, and it aims to create a lasting program that can be used in more places in the future.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Yale University NIH-funded |
| Lab location | 1 site (New Haven, United States) |
| Project ID | NIH-10872832 on NIH RePORTER |
What this research studies
This research aims to develop and test a set of brief interventions designed to prevent youth suicide among individuals aged 12-24 in Nepal. The interventions will be delivered by trained peers and will include safety planning and follow-up support, enhanced by culturally relevant strategies that involve family members. The project will collaborate with a local NGO to ensure effective implementation and will gather feedback from youth and community members to refine the approach. The goal is to create a sustainable model that can be expanded in the future.
Who could benefit from this research
Good fit: Ideal candidates for this research are youth aged 12-24 who are at risk of suicide and their families, particularly from minority ethnic backgrounds in Nepal.
Not a fit: Patients outside the age range of 12-24 or those not at risk of suicide may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce youth suicide rates and improve mental health outcomes in marginalized communities in Nepal.
How similar studies have performed: Previous research in South Asia has shown success with similar peer-delivered interventions for mental health, indicating a promising approach for this project.
Where this research is happening
New Haven, United States
- Yale University — New Haven, United States (Active)
Researchers
- Principal investigator: Hagaman, Ashley K — Yale University
- Study coordinator: Hagaman, Ashley K
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.